BEIJING TIANTAN BIOLOGICAL PRODUCTS CORPORATION LIMITED financial statements, including revenue, expenses, profit, and loss

The total revenue of 600161 for the last quarter is 1.22 B CNY, and it's 23.90% lower compared to the previous quarter. The net income of Q3 24 is 325.63 M CNY.